pramipexole has been researched along with mirtazapine in 6 studies
Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (mirtazapine) | Trials (mirtazapine) | Recent Studies (post-2010) (mirtazapine) |
---|---|---|---|---|---|
1,103 | 219 | 517 | 1,538 | 324 | 646 |
Protein | Taxonomy | pramipexole (IC50) | mirtazapine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0851 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.2239 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.1995 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 3.1623 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Transporter | Rattus norvegicus (Norway rat) | 0.26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Davis, JM; Torrey, EF | 1 |
Kato, S; Makiguchi, A; Nishida, M; Nisijima, K; Shioda, K; Suda, S | 1 |
Grasso, SA; Holtz, NA; Napier, TC; Persons, AL; Tedford, SE | 1 |
2 review(s) available for pramipexole and mirtazapine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aspirin; Benzothiazoles; Bipolar Disorder; Celecoxib; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dopamine Agonists; Estrogens; Fatty Acids, Omega-3; Folic Acid; Humans; Mianserin; Minocycline; Mirtazapine; Pramipexole; Pregnenolone; Pyrazoles; Randomized Controlled Trials as Topic; Schizophrenia; Sulfonamides; Treatment Outcome; Vitamin B Complex | 2012 |
4 other study(ies) available for pramipexole and mirtazapine
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Mirtazapine-induced restless legs syndrome treated with pramipexole.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Female; Humans; Mianserin; Mirtazapine; Pramipexole; Restless Legs Syndrome | 2015 |
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Corpus Striatum; Delay Discounting; Dopamine Agonists; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Mianserin; Mirtazapine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation; Rats, Sprague-Dawley; Risk-Taking; Self Stimulation | 2016 |